Circadia Health announces FDA clearance of The C100 System for Contactless Respiratory Monitoring

June 26th, 2020 London, United Kingdom—25 June 2020—Circadia Health announced today that it has received expedited FDA clearance for Contactless Respiration Rate (CResp®) monitoring due to COVID-19. The C100 System™ uses radar to sense wirelessly, from up to 4 feet away in adult patients. Continuous CResp will support clinicians and save patient...